HansLeeMD

PubMed

• Novel Anti-B-cell Maturation Antigen Alpha-Amanitin Antibody-drug Conjugate HDP-101 Shows Superior Activity to Belantamab Mafodotin and Enhanced Efficacy in Deletion 1...
  Singh, R., Jones, R., Shirazi, F., Qin, L., Zou, J., Hong, S., Wang, H., Wan, J., Choudhary, R., Kuiatse, I., Pahl, A., Lee, H., Patel, K., Orlowski, R.> ;Research Square. 2024 Jan 11
• INSURE: a pooled analysis of ixazomib-lenalidomide-dexamethasone for relapsed/refractory myeloma in routine practice.
  Xavier Leleu, Hans C Lee, Jeffrey A Zonder, Margaret Macro, Karthik Ramasamy, Cyrille Hulin, Jiri Silar, Matyas Kuhn, Kaili Ren, Nawal Bent-Ennakhil, Dasha Cherepanov,...> ;Future Oncology. 2024 May 1
• Outcomes of patients with multiple myeloma and 1q gain/amplification receiving autologous hematopoietic stem cell transplant: the MD Anderson cancer center experience.
  Oren Pasvolsky, Sassine Ghanem, Denái R Milton, Mikael Rauf, Mark R Tanner, Qaiser Bashir, Samer Srour, Neeraj Saini, Paul Lin, Jeremy Ramdial, Yago Nieto, Guilin Tang...> ;Blood Cancer Journal. 2024 Jan 10
• Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
  Kumar, S., Callander, N., Adekola, K., Anderson, L., Baljevic, M., Baz, R., Campagnaro, E., Castillo, J., Costello, C., D'Angelo, C., Derman, B., Devarakonda, S., Else...> ;Journal of the National Comprehensive Cancer Network. 2024 Jan 1
• Impact of pretransplant minimal residual disease in patients with multiple myeloma and a very good partial response or better receiving autologous hematopoietic stem c...
  Oren Pasvolsky, Sarah Pasyar, Roland L Bassett, Hina N Khan, Mark R Tanner, Qaiser Bashir, Samer Srour, Neeraj Saini, Paul Lin, Jeremy Ramdial, Yago Nieto, Hans C Lee,...> ;Cancer. 2024 May 1
• Management and Outcomes of Patients with Refractory Solitary Plasmacytoma after Treatment with Definitive Radiation Therapy.
  Saini, N., Becnel, M., Amini, B., Lin, P., Dabaja, B., Fang, P., Pinnix, C., Wu, S., Lee, H., Patel, K., Kaufman, G., Thomas, S., Orlowski, R., Gunther, J.> ;International Journal of Radiation Oncology, Biology, Physics. 2023 Dec 8
• 1 citations
  Multiple Myeloma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
  Shaji K Kumar, Natalie S Callander, Kehinde Adekola, Larry D Anderson Jr, Muhamed Baljevic, Rachid Baz, Erica Campagnaro, Jorge J Castillo, Caitlin Costello, Christoph...> ;Journal of the National Comprehensive Cancer Network. 2023 Dec 1
• Real-World Utilization of Radiation Therapy in Multiple Myeloma: An Analysis of the Connect MM Registry.
  Leslie Ballas, Sikander Ailawadhi, Mohit Narang, Cristina J Gasparetto, Hans C Lee, James W Hardin, Brian G M Durie, Kathleen Toomey, James Omel, Lynne I Wagner, Rafat...> ;Practical Radiation Oncology. 2023 Nov 19
• Single-agent lenalidomide maintenance after upfront autologous stem cell transplant for newly diagnosed multiple myeloma: The MD Anderson experience.
  Oren Pasvolsky, Denái R Milton, Adeel Masood, Sophiya S Sami, Mark R Tanner, Qaiser Bashir, Samer Srour, Neeraj Saini, Paul Lin, Jeremy Ramdial, Yago Nieto, Arsalan Sa...> ;American Journal of Hematology. 2023 Oct 1
• First-in-human clinical trial of personalized neoantigen vaccines as early intervention in untreated patients with lymphoplasmacytic lymphoma.
  Larry Kwak, Szymon Szymura, Lin Wang, Tiantian Zhang, Soung-Chul Cha, Zhenyuan Dong, Aaron Anderson, Elizabeth Oh, Vincent Lee, Zhe Wang, Sapna Parshottham, Sheetal Ra...> ;Research Square. 2023 Sep 21
• 2 citations
  Single-agent belantamab mafodotin in patients with relapsed/refractory multiple myeloma: Final analysis of the DREAMM-2 trial.
  Ajay K Nooka, Adam D Cohen, Hans C Lee, Ashraf Badros, Attaya Suvannasankha, Natalie Callander, Al-Ola Abdallah, Suzanne Trudel, Ajai Chari, Edward N Libby, Maria Chau...> ;Cancer. 2023 Dec 1
• Outcomes of young adults (aged ≤ 40 years) with newly diagnosed multiple myeloma after up-front autologous stem cell transplant.
  Oren Pasvolsky, Curtis Marcoux, Denái R Milton, Mark R Tanner, Qaiser Bashir, Samer Srour, Neeraj Saini, Paul Lin, Jeremy Ramdial, Yago Nieto, Hans C Lee, Krina K Pate...> ;British Journal of Haematology. 2023 Aug 1
• 6 citations
  Single cell clonotypic and transcriptional evolution of multiple myeloma precursor disease.
  Minghao Dang, Ruiping Wang, Hans C Lee, Krina K Patel, Melody R Becnel, Guangchun Han, Sheeba K Thomas, Dapeng Hao, Yanshuo Chu, Donna M Weber, Pei Lin, Zuzana Lutter-...> ;Cancer Cell. 2023 Jun 12
• 2 citations
  Impact of gender on outcomes of patients with multiple myeloma undergoing autologous Haematopoietic stem cell transplant.
  Oren Pasvolsky, Rima M Saliba, Adeel Masood, Ali H Mohamedi, Mark R Tanner, Qaiser Bashir, Samer Srour, Neeraj Saini, Jeremy Ramdial, Yago Nieto, Hans C Lee, Krina K P...> ;British Journal of Haematology. 2023 May 1
• Effect of anti-CD38 monoclonal antibodies on hepatitis C virus replication in chronically infected patients with multiple myeloma: a prospective series.
  Chia-Yu Chiu, Khalis Mustafayev, Hans C Lee, Elisabet E Manasanch, Harrys A Torres, Yepez Guevara, E.> ;Leukemia & Lymphoma. 2023 Apr 1
• 4 citations
  Autologous Stem Cell Transplantation for Patients with Multiple Myeloma with Translocation (4;14): The MD Anderson Cancer Center Experience.
  Oren Pasvolsky, Mahmoud R Gaballa, Denái R Milton, Adeel Masood, Sophiya S Sami, Mark R Tanner, Qaiser Bashir, Samer Srour, Neeraj Saini, Jeremy Ramdial, Yago Nieto, G...> ;Transplantation and Cellular Therapy. 2023 Apr 1
• 5 citations
  Systemic Light Chain Amyloidosis, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.
  Shaji K Kumar, Natalie S Callander, Kehinde Adekola, Larry D Anderson Jr, Muhamed Baljevic, Erica Campagnaro, Jorge J Castillo, Caitlin Costello, Christopher D'Angelo,...> ;Journal of the National Comprehensive Cancer Network. 2023 Jan 1
• Radiation Therapy Can Be Safely Incorporated into Pretransplantation Treatment Regimens for Patients with Multiple Myeloma.
  Ethan P Damron, Muzaffar H Qazilbash, Penny Q Fang, Susan Y Wu, Bouthaina S Dabaja, Gabriela Rondon, Chitra Hosing, Richard E Champlin, Qaiser Bashir, Elizabeth J Shpa...> ;Transplantation and Cellular Therapy. 2023 Jan 1
• Rates of Influenza and Pneumococcal Vaccination and Correlation With Survival in Multiple Myeloma Patients.
  Michael A Thompson, Mario Boccadoro, Xavier Leleu, Jorge Vela-Ojeda, Frits van Rhee, Katja C Weisel, Robert M Rifkin, Saad Z Usmani, Roman Hájek, Gordon Cook, Rafat Ab...> ;Clinical Lymphoma, Myeloma & Leukemia. 2023 Mar 1
• 3 citations
  Hepatitis B virus reactivation in patients with past HBV infection receiving anti-CD38 monoclonal antibodies.
  Chia-Yu Chiu, Krina Patel, Sheeba K Thomas, Fareed Khawaja, Natalie J M Dailey Garnes, Hans C Lee, Maro Ohanian, Ying Jiang, Lan S Wang, Jessica P Hwang, Harrys A Torres> ;Hepatology International. 2023 Apr 1
• 4 citations
  Treatment Patterns, Survival, Quality of Life, and Healthcare Resource Use Among Patients With Triple-Class Refractory Multiple Myeloma in US Clinical Practice: Findin...
  Hans C Lee, Karthik Ramasamy, Katja Weisel, Rafat Abonour, James W Hardin, Robert M Rifkin, Sikander Ailawadhi, Howard R Terebelo, Brian G M Durie, Derek Tang, Prashan...> ;Clinical Lymphoma, Myeloma & Leukemia. 2023 Feb 1
• Antibody Drug Conjugates in Multiple Myeloma.
  Christopher J Ferreri, Hans C Lee> ;Cancer Journal. 2022 Nov 16
• 3 citations
  Lenalidomide-Based Maintenance after Autologous Hematopoietic Stem Cell Transplantation for Patients with High-Risk Multiple Myeloma.
  Oren Pasvolsky, Denái R Milton, Mikael Rauf, Mark R Tanner, Qaiser Bashir, Samer Srour, Guilin Tang, Neeraj Saini, Jeremy Ramdial, Adeel Masood, Yago Nieto, Hans C Lee...> ;Transplantation and Cellular Therapy. 2022 Nov 1
• Quantitation of navtemadlin in human plasma and brain tissue by liquid chromatography-tandem mass spectrometry.
  Amanda B Kagan, Nicole M Anders, Avelina Hemingway, Eudocia Q Lee, Kevin R Kelly, Hans C Lee, Meng Xu-Welliver, Richard Piekarz, Michelle A Rudek> ;Biomedical Chromatography. 2022 Nov 1
• 3 citations
  Clinical efficacy of sequencing CD38 targeting monoclonal antibodies in relapsed refractory multiple myeloma: A multi-institutional experience.
  Meera Mohan, Melody Renee Becnel, Urvi A Shah, Huaying Dong, Sravani Gundarlapalli, Timothy Peterson, Jennifer S Orozco, Sandra Horowitz, Saurabh Chhabra, Binod Dhakal...> ;American Journal of Hematology. 2022 Jul 1
• Join now to see all

Journal Articles

• Primary Plasma Cell Leukemia: Autologous Stem Cell Transplant in an Era of Novel Induction Drugs  
  Krina Patel, Rohtesh Mehta, Donna M Weber, Sheeba K Thomas, Nina Shah, Hans C Lee, Elisabet E Manasanch, Muzaffar H Qazilbash, Qaiser Bashir, Simrit Parmar, Robert Z O..., Nature
• Targeting Myddosome Signaling in Waldenström's Macroglobulinemia with the Interleukin-1 Receptor-Associated Kinase 1/4 Inhibitor R191  
  Sheeba K Thomas, Robert Z Orlowski, Hans C Lee, Clinical Cancer Research

Abstracts/Posters

• A Multicenter Phase II Single Arm Trial of Isatuximab in Patients with High Risk Smoldering Multiple Myeloma (HRSMM)
  Hans C. Lee, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Outcomes of Lenalidomide Retreatment with Novel Triplet Regimens in Multiple Myeloma Patients Progressing on Lenalidomide-Based Maintenance Therapy: A Single Center Re...
  Hans C. Lee, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Closing the Efficacy and Effectiveness Gap: Outcomes in Relapsed/Refractory Multiple Myeloma (RRMM) Patients (Pts) Treated with Ixazomib-Lenalidomide-Dexamethasone (IR...
  Hans C. Lee, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• A Multicenter Phase II Single Arm Trial of Isatuximab in Patients with High Risk Smoldering Multiple Myeloma (HRSMM)
  Hans C. Lee, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• A Phase 1/2 Study to Assess Safety and Dose of Ixazomib in Combination with Cyclophosphamide and Dexamethasone in Newly Diagnosed Patients with Light Chain (AL) Amyloi...
  Hans C. Lee, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Clinical Outcomes and Health-Related Quality of Life (HRQoL) Among Randomized Clinical Trial (RCT)-Eligible and RCT-Ineligible Patients: Results from the Connect¬ MM R...
  Hans C. Lee, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Real-World (RW) Multiple Myeloma (MM) Patients (Pts) Remain Under-Represented in Clinical Trials Based on Standard Laboratory Parameters and Baseline Characteristics: ...
  Hans C. Lee, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Join now to see all

Lectures

• A 3D Learning Experience: Novel Combination Treatment Options and Sequencing Strategies for Personalized Management of Relapsed and/or Refractory Multiple Myeloma 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
• Treatment Patterns and Outcomes in Elderly Patients with Newly Diagnosed Multiple Myeloma: Results from the Connect¬ MM Registry 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019